AltheaDx Raises $30M In Series C

San Diego-based personalized medicine technology developer AltheaDx has raised $30M in a Series C funding, according to the company. The funxing was led by WuXi Healthcare Ventures, and also included WuXi PharmaTech, Ally Bridge Group and ALMA Life Sciences. AltheaDx is developing testing technology which helps patients with cardiovascular disease, neuropsychiatric disorders and pain. The company said the funds go towards product enhancements international opportunities, and other efforts. More information »